跳至主要内容
临床试验/NCT00490893
NCT00490893终止4 期

Effects of Insulin Detemir Versus Regular Insulin (Actrapid) on Hormonal Counterregulation, Cognitive Function and Symptom Perception During Hypoglycemia

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2006年3月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
12
试验地点
2
主要终点
Hormone response to hypoglycemia (Glucagon)

研究概览

简要总结

Hypoglycemia and unawareness of hypoglycemia are major problems of insulin therapy in patients with diabetes mellitus. The long acting insulin analogue Detemir has structural and physicochemical properties which differ from human insulin. The aim of the present study is to test whether this leads to altered hormone and symptom response during hypoglycemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Single

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects male or female
  • Age 18-50 years
  • Female subjects save contraception
  • Ability to take part in the study
  • Signed consent

排除标准

  • Chronic disease
  • Acute disease during 4 weeks prior to the study
  • Pregnancy
  • Drug treatment other than hormonal contraception

结局指标

主要结局

Hormone response to hypoglycemia (Glucagon)

Hormone response to hypoglycemia (glucagon) Symptom response to hypoglycemia

次要结局

  • Hormone response to glucagon (epinephrine, growth hormne, cortisol)
  • Hormone response (epinephrine, growth hormone, cortisol) to hypoglycemia

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验